• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JSI-124 通过抑制 STAT3 的组成性激活,增强人 B 白血病细胞对凋亡的敏感性。

Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis.

机构信息

Departments of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

Mol Cancer Ther. 2010 Dec;9(12):3302-14. doi: 10.1158/1535-7163.MCT-10-0550.

DOI:10.1158/1535-7163.MCT-10-0550
PMID:21159613
Abstract

Phosphorylation of STAT3 on serine 727 regulates gene expression and is found to be elevated in many B-leukemia cells including chronic lymphocytic leukemia (CLL). It is, however, unclear whether targeting STAT3 will be an effective antileukemia therapy. In this study, we assessed in vitro antileukemia activity of the STAT3 inhibitor JSI-124 (cucurbitacin I). JSI-124 potently induces apoptosis in 3 B-leukemia cell lines (BJAB, I-83, and NALM-6) and in primary CLL cells and was associated with a reduction in serine 727 phosphorylation of STAT3. Similarly, knockdown of STAT3 expression induced apoptosis in these leukemia cells. In addition, we found that JSI-124 and knockdown of STAT3 decreased antiapoptotic protein XIAP expression and overexpression of XIAP blocked JSI-124-induced apoptosis. Furthermore, we found that combined treatment of JSI-124 and TRAIL increased apoptosis associated with an increase in death receptor 4 expression. Besides apoptosis, we found that JSI-124 also induced cell-cycle arrest prior to apoptosis in B-leukemia cells. This corresponded with reduced expression of the cell-cycle regulatory gene, cdc-2. Thus, we present here for the first time that JSI-124 induced suppression of serine 727 phosphorylation of STAT3, leading to apoptosis and cell-cycle arrest through alterations in gene transcription in B-leukemia cells.

摘要

磷酸化的 STAT3 在丝氨酸 727 上的调节基因表达,并被发现在许多 B 白血病细胞中升高,包括慢性淋巴细胞白血病(CLL)。然而,目前尚不清楚针对 STAT3 是否将是一种有效的抗白血病治疗方法。在这项研究中,我们评估了 STAT3 抑制剂 JSI-124(葫芦素 I)在体外的抗白血病活性。JSI-124 能强烈诱导 3 种 B 白血病细胞系(BJAB、I-83 和 NALM-6)和原发性 CLL 细胞的凋亡,并与 STAT3 的丝氨酸 727 磷酸化减少相关。同样,STAT3 表达的敲低也诱导这些白血病细胞凋亡。此外,我们发现 JSI-124 和 STAT3 的敲低降低了抗凋亡蛋白 XIAP 的表达,而 XIAP 的过表达则阻断了 JSI-124 诱导的凋亡。此外,我们发现 JSI-124 和 TRAIL 的联合治疗增加了与死亡受体 4 表达增加相关的凋亡。除了凋亡,我们还发现 JSI-124 还在 B 白血病细胞中诱导凋亡前的细胞周期停滞。这与细胞周期调节基因 cdc-2 的表达减少相对应。因此,我们在这里首次提出,JSI-124 诱导 STAT3 的丝氨酸 727 磷酸化抑制,导致 B 白血病细胞中的凋亡和细胞周期停滞,通过改变基因转录。

相似文献

1
Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis.JSI-124 通过抑制 STAT3 的组成性激活,增强人 B 白血病细胞对凋亡的敏感性。
Mol Cancer Ther. 2010 Dec;9(12):3302-14. doi: 10.1158/1535-7163.MCT-10-0550.
2
Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.葫芦素 I(JSI-124)在 B 白血病细胞中通过非凋亡和细胞周期阻滞激活 JNK/c-Jun 信号通路。
BMC Cancer. 2011 Jun 24;11:268. doi: 10.1186/1471-2407-11-268.
3
Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.STAT3 抑制剂 JSI-124 激活人胶质母细胞瘤细胞中的 NF-κB 通路。
Mol Cancer Res. 2013 May;11(5):494-505. doi: 10.1158/1541-7786.MCR-12-0528. Epub 2013 Feb 5.
4
Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses.死亡受体 4 优先募集到慢性淋巴细胞白血病细胞中的脂筏中,有助于肿瘤坏死相关凋亡诱导配体诱导的协同凋亡反应。
Leuk Lymphoma. 2011 Jul;52(7):1290-301. doi: 10.3109/10428194.2011.567317.
5
Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.JSI-124(葫芦素I)的发现,一种选择性的Janus激酶/信号转导及转录激活因子3信号通路抑制剂,对小鼠体内的人源和鼠源癌细胞具有强大的抗肿瘤活性。
Cancer Res. 2003 Mar 15;63(6):1270-9.
6
Novel X-linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL-mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis.新型 X 连锁凋亡抑制因子抑制化合物作为 TRAIL 介导凋亡的增敏剂在预后不良的慢性淋巴细胞白血病中的应用。
Br J Haematol. 2011 Jan;152(2):191-200. doi: 10.1111/j.1365-2141.2010.08426.x. Epub 2010 Nov 23.
7
JSI-124 inhibits glioblastoma multiforme cell proliferation through G(2)/M cell cycle arrest and apoptosis augment.JSI-124通过G(2)/M期细胞周期阻滞和增强细胞凋亡来抑制多形性胶质母细胞瘤细胞增殖。
Cancer Biol Ther. 2008 Aug;7(8):1243-9. doi: 10.4161/cbt.7.8.6263. Epub 2008 Aug 10.
8
JSI-124 (Cucurbitacin I) inhibits tumor angiogenesis of human breast cancer through reduction of STAT3 phosphorylation.JSI-124(葫芦素 I)通过降低 STAT3 磷酸化抑制人乳腺癌肿瘤血管生成。
Am J Chin Med. 2015;43(2):337-47. doi: 10.1142/S0192415X15500226. Epub 2015 Mar 19.
9
A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.一种引发慢性淋巴细胞白血病细胞凋亡的新范式。
Cancer Res. 2009 Dec 1;69(23):8977-86. doi: 10.1158/0008-5472.CAN-09-2604. Epub 2009 Nov 17.
10
JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells.JSI-124(葫芦素I)抑制Janus激酶-3/信号转导及转录激活因子-3信号通路,下调核仁磷酸蛋白-间变性淋巴瘤激酶(ALK),并诱导ALK阳性间变性大细胞淋巴瘤细胞凋亡。
Br J Haematol. 2006 Oct;135(1):26-32. doi: 10.1111/j.1365-2141.2006.06259.x. Epub 2006 Aug 25.

引用本文的文献

1
Synergistic MDM2-STAT3 Inhibition Demonstrates Strong Anti-Leukemic Efficacy in Acute Lymphoblastic Leukemia.MDM2与STAT3协同抑制在急性淋巴细胞白血病中显示出强大的抗白血病疗效。
Int J Mol Sci. 2025 Sep 5;26(17):8648. doi: 10.3390/ijms26178648.
2
Interleukin-6 serves as a critical factor in various cancer progression and therapy.白细胞介素-6 在多种癌症的发生和治疗中起着关键作用。
Med Oncol. 2024 Jun 20;41(7):182. doi: 10.1007/s12032-024-02422-5.
3
Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells.
非典型转录调控在慢性淋巴细胞白血病和正常 B 细胞中对预后不良因子 UGT2B17 的作用。
BMC Cancer. 2024 Apr 2;24(1):410. doi: 10.1186/s12885-024-12143-7.
4
JSI-124 Induces Cell Cycle Arrest and Regulates the Apoptosis in Glioblastoma Cells.JSI-124诱导胶质母细胞瘤细胞的细胞周期停滞并调节其凋亡。
Biomedicines. 2023 Nov 8;11(11):2999. doi: 10.3390/biomedicines11112999.
5
Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.葫芦素在癌症中的凋亡和抗转移作用:最新趋势和进展。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep;396(9):1867-1878. doi: 10.1007/s00210-023-02471-z. Epub 2023 Apr 3.
6
STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.STAT3 激活慢性淋巴细胞白血病细胞中的 Pentraxin 3 基因。
J Immunol. 2022 Jun 15;208(12):2847-2855. doi: 10.4049/jimmunol.2101105. Epub 2022 May 20.
7
The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer.白细胞介素6样细胞因子家族:在乳腺癌中的作用及作为生物标志物的潜力
J Pers Med. 2021 Oct 24;11(11):1073. doi: 10.3390/jpm11111073.
8
Combination of ERK2 and STAT3 Inhibitors Promotes Anticancer Effects on Acute Lymphoblastic Leukemia Cells.ERK2 和 STAT3 抑制剂的联合使用可增强对急性淋巴细胞白血病细胞的抗癌作用。
Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):517-527. doi: 10.21873/cgp.20208.
9
Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers.植物化学物靶向 STAT3 调控治疗抵抗性癌症中的脂代谢。
Biomolecules. 2020 Jul 28;10(8):1118. doi: 10.3390/biom10081118.
10
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.造血系统癌症中致癌性 STAT3 和 STAT5 信号通路的药理学抑制作用
Cancers (Basel). 2020 Jan 18;12(1):240. doi: 10.3390/cancers12010240.